The present invention is directed to substituted certain N-heteroaryl
indazole derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, X, Y, and Z are as defined herein, which are potent inhibitors of LRRK2
kinase and may be useful in the treatment or prevention of diseases in which the LRRK2
kinase is involved, such as Parkinson's
Disease and other diseases and disorders described herein. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of diseases, such as Parkinson's
disease, in which LRRK-2
kinase is involved.